PMID 33581247
Before You Start: A thorough medical evaluation is a must
Semaglutide benefits beyond weight loss In a related editorial published in The Lancet , Camilla Hage, PhD, associate professor in the division of cardiology, department of medicine at Karolinska Institutet in Stockholm, said more research is needed to determine whether semaglutide and GLP-1 receptor agonists lower the risk for worsening HF among adults without overweight or obesity, as the risk reduction in the pooled analysis may be due to weight loss
Skin redness at the injection site
Third, individual-level patient data (IPD) were not available, limiting our ability to adjust for important confounders such as smoking, alcohol intake, family history, and genetic risk
Patients should never attempt to withdraw medication from these pens or perform dose conversions independently without explicit guidance from their prescribing clinician or pharmacist